Ex-Dividend Reminder: Sabra Health Care REIT, Selective Insurance Group and Esquire Financial Holdings

On 2/13/26 Sabra Health Care REIT (SBRA), Selective Insurance Group (SIGI) and Esquire Financial Holdings (ESQ) trade ex-dividend for quarterly payouts of $0.30, $0.43 and $0.20, with payment dates of 2/27/26 for SBRA and 3/2/26 for SIGI and ESQ. Based on SBRA's recent $19.15 price the $0.30 dividend implies an approximate 1.57% one-day adjustment (annualized yield ~6.27%), while SIGI and ESQ imply ~0.48% and ~0.18% one-day adjustments and annualized yields of 1.93% and 0.71%; intraday moves cited were SBRA +0.3%, SIGI +0.7% and ESQ -2.5%.

Analysis

Market structure: The immediate winners are income-oriented holders and short-term buyers who bid for SBRA’s ~6.27% annualized yield; mechanically SBRA will gap ≈1.57% on 2/13/26, SIGI ≈0.48%, ESQ ≈0.18%. This is a micro liquidity/sharing-of-yield event rather than a fundamentals shock — expect mean reversion in 3–10 trading days unless macro rates move. Cross-asset: a 10 bps move in 10y Treasury materially re-rates REITs; a 25–50 bps drop in 10y would likely lift SBRA 5–10% on multiple expansion and tighten credit spreads for healthcare REITs.

Risk assessment: Tail risks for SBRA include operator insolvency and adverse Medicare/Medicaid policy (low-probability, high-impact) and for SIGI/ESQ underwriting losses or reserve shocks. Time horizons: ex-div mechanical move (days), operational/earnings/occupancy updates (weeks–months), and interest-rate/credit-cycle impacts (12–24 months). Hidden dependencies: SBRA’s NAV and dividend sustainability hinge on tenant concentration and Medicare mix — monitor top-5 operator exposure and occupancy trends. Catalysts: CMS guidance, 10y Treasury moves, and quarterly occupancy/earnings releases.

Trade implications: Direct: establish a hedged income entry in SBRA (see decisions) rather than dividend-capture; small core buy in SIGI for stable insurance cash flow and covered-call income; avoid or short ESQ if it fails to recover its 50-day MA within 30 trading days. Options: use 3–6 month protective puts under long SBRA positions and sell 1–2 month covered calls on SIGI to enhance yield. Pair: long SIGI vs short ESQ to play dividend stability over small-cap financial risk.

Contrarian angles: Consensus treats ex-div as neutral; we see potential mispricing — SBRA yield >6% is attractive if top-5 operator exposure <40% and occupancy stable; if those metrics deteriorate the market will re-rate down sharply. Historical parallels: healthcare REITs outperformed after rate declines but underperformed during operator failures (2018–2020); unintended consequence: chasing yield without hedges can lock in capital losses if credit widens.

Key Decisions for Investors

• Establish a 1.5–3% portfolio position long SBRA (buy between $17.50–$19.50) within next 2 weeks; hedge with a 3-month SBRA 17.50 put (cost limit 1–1.5% of position) and target 12-month total return of 15–25%; stop-loss if price < $16.50.
• Add a 1–2% position long SIGI as a defensive insurance cash-flow play; sell 4–6 week covered calls ~5% out-of-the-money to boost yield; trim if dividend payout ratio exceeds 60% on next earnings report (within 60 days).
• Initiate a 0.5–1% short position in ESQ (or buy inverse small-cap financial ETF exposure) if ESQ fails to reclaim its 50-day MA within 30 trading days or if Q1 loan-loss provisioning rises >25% QoQ; cap risk with a buy-to-cover limit at 8% adverse move.
• Pair trade: long SIGI (1–2%) vs short ESQ (0.5–1%) to express dividend stability vs regional/smaller-financial stress for a 3–6 month horizon; rebalance if spread tightens/widens by >150 bps.
• Avoid dividend-capture trades around the ex-div dates; expected mechanical gaps (SBRA ~1.57%) make capture uneconomic after trading costs — instead prefer buy-and-hedge income structures within 1–12 month timeframes.